CORONA Share Price Today - Corona Remedies on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,878.20	#1 4,50,643.09	40.81	#1 54,729.00	9.71	#1 10,980	16.07	63.20
Divis Laboratories	6,760.50	1,79,470.03	74.13	9,712.00	18.67	2,191	-1.02	76.54
Torrent Pharmaceuticals	4,405.70	1,49,108.91	65.68	11,539.40	6.99	1,911	26.24	58.43
Cipla	1,432.10	1,15,682.27	30.09	27,711.70	-2.46	3,783	-55.32	70.81
Dr Reddys Laboratories	1,336.70	1,11,566.73	26.16	33,593.30	-0.44	3,998	-86.05	54.59
Lupin	2,276.20	1,04,032.18	#1 19.28	27,487.50	19.98	5,345	#1 87.72	43.90
Mankind Pharma	2,503.00	1,03,325.11	56.36	12,744.20	20.90	2,007	7.65	70.95
Zydus Life Science	1,011.70	1,01,800.69	19.85	23,511.00	18.55	4,615	-0.32	66.36
Aurobindo Pharma	1,511.80	87,805.59	25.16	32,345.60	9.43	3,484	7.59	73.72
Laurus Labs	1,323.60	71,455.42	79.78	6,812.90	#1 21.03	884	21.18	79.66

Quarterly Financials	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026
Revenue	293	316	299	295	349	364	345	358
Expenses	242	247	228	240	277	283	278	291
EBITDA	51	69	70	56	72	81	66	66
Operating Profit %	17 %	21 %	23 %	18 %	20 %	22 %	19 %	18 %
Depreciation	8	9	10	10	9	9	9	10
Interest	3	3	2	2	2	2	2	1
Profit Before Tax	39	57	58	44	61	70	55	55
Tax	9	14	13	12	15	18	14	9
Net Profit	30	43	45	32	46	52	41	45
EPS in ₹	4.90	7.03	7.35	5.16	7.55	8.55	6.75	7.41

Balance Sheet	2023	2024	2025	2026
Total Assets	595	831	930	1,205
Fixed Assets	185	384	370	723
Current Assets	292	290	339	348
Capital Work in Progress	65	121	186	143
Investments	32	26	26	125
Other Assets	314	301	348	0
Total Equity & Liabilities	595	831	930	1,205
Current Liabilities	137	224	240	361
Non Current Liabilities	49	126	84	97
Total Equity	409	480	606	747
Reserve & Surplus	347	419	545	686
Share Capital	61	61	61	61

Cash Flow	2023	2024	2025
Net Cash Flow	8	-11	0
Investing Activities	-50	-267	-84
Operating Activities	103	157	191
Financing Activities	-45	99	-107

% Holding	Apr 2025	Dec 2025	Mar 2026
Promoter	72.50 %	69.00 %	69.00 %
FIIs	0.00 %	1.84 %	2.25 %
DIIs	0.00 %	6.76 %	7.02 %
Government	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	1.36 %	0.77 %
Others	27.50 %	21.05 %	20.97 %
No of Share Holders	9	9	19,609

Annual Cash Flows	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Dividend Per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.31	0.00
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.47	0.00

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
19 Jun 2026	Dividend	₹ 10.00 /share	19 Jun 2026	1,712.15	1,783.15
02 Jan 2026	Quarterly Result Announcement	NA	02 Jan 2026	1,347.70	1,402.95
02 Feb 2026	Quarterly Result Announcement	NA	02 Feb 2026	1,404.80	1,447.75
11 May 2026	Quarterly Result Announcement	NA	11 May 2026	1,689.20	1,712.15

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
ICICI Prudential Quality Fund Direct-Growth	0.00%	-14027	-0.11%	-0.59%
WhiteOak Capital Consumption Opportunities Fund Direct-Growth	1.53%	616	0.01%	0.09%
Invesco India Multicap Fund Direct-Growth	1.21%	0	0.00%	0.23%
Kotak Healthcare Fund Direct-Growth	1.91%	0	0.00%	-0.02%
Bandhan BSE Healthcare Index Fund Direct-Growth	0.05%	0	0.00%	0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth	0.00%	0	0.00%	0.00%
DSP Healthcare Fund Direct-Growth	0.15%	0	0.00%	-0.48%
Edelweiss Recently Listed IPO Fund Direct-Growth	1.93%	0	0.00%	-0.16%
Franklin India Large & Mid Cap Fund Direct-Growth	0.00%	0	0.00%	0.00%
Groww Nifty Total Market Index Fund Direct-Growth	0.00%	0	0.00%	0.00%
HDFC Pharma And Healthcare Fund Direct-Growth	0.00%	0	0.00%	0.00%
Axis Business Cycles Fund Direct-Growth	0.65%	0	0.00%	0.00%
Invesco India Consumption Fund Direct-Growth	2.52%	0	0.01%	0.25%
Invesco India ELSS Tax Saver Fund Direct-Growth	0.65%	0	0.00%	0.31%
Invesco India Large & Mid Cap Fund Direct-Growth	0.44%	0	0.00%	-0.02%
Invesco India Mid Cap Fund Direct-Growth	1.03%	0	0.00%	-0.07%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth	2.24%	0	0.00%	0.12%
Invesco India Smallcap Fund Direct-Growth	2.19%	0	0.00%	-0.18%
Axis Equity Savings Fund Direct-Growth	0.79%	0	0.00%	0.06%
Mirae Asset Healthcare Fund Direct-Growth	0.00%	0	0.00%	0.00%
Kotak Consumption Fund Direct-Growth	0.60%	0	0.00%	0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth	0.00%	0	0.00%	0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth	0.09%	0	0.00%	-0.01%
SBI Healthcare Opportunities Fund Direct Plan-Growth	0.00%	0	0.00%	-0.29%
Tata India Pharma & Healthcare Fund Direct-Growth	0.77%	0	0.00%	0.02%

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Corona Remedies

Company News

Peer Comparison Compare Peers on Screener

Automatic Screeners on ScanX

Quarterly Financial Results

Balance Sheet

Cash Flow

Share Holding

Dividend History

Corporate Action

Announcements

Mutual Fund Holdings

Technical Indicators